OverviewSuggest Edit

Bayer is a global life science company specializing in healthcare and nutrition. The company operates in three segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment engages in the development, production, and marketing of seeds, plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health, specialty therapeutics in the areas of oncology, hematology, and ophthalmology, as well as diagnostic imaging equipment and contrast agents. The Consumer Health segment offers nonprescription over-the-counter medicines, medical products, cosmetics and other self-care solutions in the categories of dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cough and cold.

TypePublic
Founded1863
HQLeverkusen, DE
Websitebayer.com

Latest Updates

Employees (est.) (Dec 2019)103,824
Job Openings988
Revenue (FY, 2019)€43.5 B(+11%)
Share Price (Nov 2020)€47.6
Cybersecurity ratingCMore

Key People/Management at Bayer

Werner Baumann

Werner Baumann

Chairman of the Board of Management, CEO
Liam Condon

Liam Condon

Member of the Board of Management, Crop Science
Wolfgang Nickl

Wolfgang Nickl

Member of the Board of Management, Finance
Stefan Oelrich

Stefan Oelrich

Member of the Board of Management, Pharmaceuticals
Heiko Schipper

Heiko Schipper

Member of the Board of Management, Consumer Health
Brett Begemann

Brett Begemann

Chief Operating Officer, Crop Science
Show more

Bayer Office Locations

Bayer has offices in Leverkusen, Bergkamen, Berlin, Bitterfeld-Wolfen and in 102 other locations
Leverkusen, DE (HQ)
Bayer Aktiengesellschaft, Kaiser-Wilhelm-Allee 1
Bergkamen, DE
Ernst-Schering-Straße 14
Berlin, DE
Müllerstraße 7
Bitterfeld-Wolfen, DE
Salegaster Chaussee 1
Burscheid, DE
Sträßchen 30
Frankfurt am Main, DE
Brüningstraße 50
Show all (107)

Bayer Financials and Metrics

Bayer Revenue

Embed Graph
View revenue for all periods
Bayer's revenue was reported to be €43.55 b in FY, 2019 which is a 10% increase from the previous period.
EUR

Revenue (FY, 2019)

43.5b

Revenue growth (FY, 2018 - FY, 2019), %

10%

Gross profit (FY, 2019)

26.1b

Gross profit margin (FY, 2019), %

59.9%

Net income (FY, 2019)

2.4b

EBIT (FY, 2019)

4.2b

Market capitalization (17-Nov-2020)

46.5b

Closing stock price (17-Nov-2020)

47.6

Cash (31-Dec-2019)

3.2b

EV

82.5b
Bayer's current market capitalization is €46.5 b.
Annual
EURFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

46.8b35.0b39.6b43.5b

Revenue growth, %

1%(25%)13%10%

Cost of goods sold

20.3b11.4b17.0b17.5b

Gross profit

26.5b23.6b22.6b26.1b
Quarterly
EURQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

11.9b11.8b11.3b13.2b12.2b8.0b9.1b9.5b9.9b13.0b11.5b9.8b

Cost of goods sold

5.1b5.0b4.8b5.3b5.1b2.6b2.9b3.5b4.5b5.3b4.4b3.7b

Gross profit

6.9b6.8b6.4b7.9b7.1b5.5b6.2b6.0b5.4b7.8b7.1b6.1b

Gross profit Margin, %

57%58%57%60%58%68%68%63%54%60%62%62%
Annual
EURFY, 2016FY, 2017FY, 2018FY, 2019

Cash

1.9b7.6b4.1b3.2b

Accounts Receivable

11.0b8.6b11.8b11.7b

Inventories

8.4b6.6b11.0b10.8b

Current Assets

30.4b30.1b30.9b32.6b
Quarterly
EURQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

3.6b1.1b1.2b2.2b2.8b5.6b5.3b5.0b4.9b4.1b3.3b4.4b

Accounts Receivable

11.6b11.8b10.8b13.0b12.1b8.8b9.5b14.3b11.7b14.3b14.2b11.9b

Inventories

8.5b8.3b8.4b8.7b8.5b6.7b6.4b11.1b11.1b10.7b10.4b10.5b

Current Assets

26.7b24.7b25.2b33.4b32.7b30.8b33.2b37.8b32.1b32.7b32.8b33.5b
Annual
EURFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

4.5b7.3b1.7b2.4b

Depreciation and Amortization

3.7b2.7b6.4b5.4b

Inventories

(3.0m)(293.0m)615.0m(103.0m)

Accounts Payable

452.0m265.0m(44.0m)759.0m
EURQ1, 2016

EV/EBIT

48.4 x

EV/CFO

85.4 x

Debt/Equity

0.8 x

Debt/Assets

0.3 x

Financial Leverage

3.1 x
Show all financial metrics

Bayer Operating Metrics

FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Countries

147 151 152 148 153

Suppliers

112 k112.50 k110.90 k93.33 k101.19 k86.40 k

Patent Applications

68.20 k66.70 k50.80 k48.10 k

Patents Issued

8.30 k7.20 k5 k4.70 k
Show all operating metrics

Bayer Acquisitions / Subsidiaries

Company NameDateDeal Size
KaNDy TherapeuticsAugust 14, 2020$450 m
BlueRock TherapeuticsAugust 08, 2019$1 b
Monsanto CompanyMay 23, 2016$62.50 b
Zoner.agFebruary 15, 2015
Dihon PharmaceuticalNovember 05, 2014€460 m
Merck-Consumer Care (MCC)October 01, 2014$14.20 b
AlgetaDecember 19, 2013$2.90 b
AgraQuest, Inc.July 01, 2012$425 m
Artificial Muscle IncMarch 11, 2010
Icon GeneticsFebruary 13, 2006
Show more

Bayer Revenue Breakdown

Embed Graph

Bayer revenue breakdown by business segment: 12.5% from Consumer Health, 41.2% from Pharmaceuticals, 45.5% from CropScience and 0.7% from Other

Bayer revenue breakdown by geographic segment: 15.3% from Latin America, 19.8% from Asia / Pacific, 34.6% from North America and 30.3% from Europe / Middle East / Africa

Human Capital Metrics

Bayer's employees are reported to be approximately 40% female and 60% male.
Embed Graph
Show all human capital metrics

Bayer Cybersecurity Score

Cybersecurity ratingPremium dataset

C

74/100

SecurityScorecard logo

Bayer Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Bayer Online and Social Media Presence

Embed Graph

Bayer News and Updates

Why it was a 'no brainer' for ag giant Bayer to launch the industry's first blockchain initiative to track crops from seed-to-sale with startup partner BlockApps

Summary List Placement All growers are not created equal. At least, that was the mindset that Bayer and other agriculture giants had — until now.   While many farmers are capable of growing standard soybean crops, companies like Bayer often release specific seeds that can produce higher yields or h…

Europe Antibiotics Market to grow at a CAGR 3.1% to reach US$ 15,569.87 million From 2020 to 2027 | Top Key Players Like Sanofi, Novartis AG, Bayer AG, Pfizer Inc

​Antibiotic is a group of medicines that fights bacterial infections, and sometimes protozoan diseases. Moreover, they are used to treat many diseases such as strep throat, urinary tract infections, sinus infections, pneumonia, eye & ear infections, and others. Antibiotics are also called antimi…

Europe Chronic Cough Market Set to Expand by 2020-2027 Focusing on Key Players Novartis AG, GlaxoSmithKline plc., Bayer AG, Mylan N.V., Cipla Inc., Reckitt Benckiser Group plc

Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the patients’ lives by interrupting sleeping, vomiting, light-headedness, and even rib fractures. It is caused due to multiple reasons such as infections, asthma, gastroesophageal reflux disease …

Covid-19 Impact on Asia Pacific Pharmaceutical Drug Delivery Market Growth and Trends to 2020-2027 With Top Companies Like 3M, Antares Pharma, Bayer AG, BD, GlaxoSmithKline plc

The Asia Pacific pharmaceutical drug delivery market is expected to reach US$ 473,700.1 Mn by 2027 from US$ 277,589.9 Mn in 2019. The market is anticipated to grow at a CAGR of 7.1% from 2020 to 2027. Posted via Industry Today. Follow us on Twitter @IndustryToday

Bayer to Spend Up to $4 Billion for AskBio’s Gene Therapies

Bayer to Acquire Biotech AskBio for as Much as $4 Billion

Europe OTC Drug and Dietary Supplement Market Set to Witness Huge Growth by 2027 | Top Vendors Like GlaxoSmithKline plc., Sanofi, Abbott, AbbVie Inc., Bayer AG, Novartis AG

The Europe OTC Drug and Dietary Supplement market is expected to reach US$ 141,676.3 million in 2027 from US$ 85,835.9 million in 2019. The market is anticipated to grow with a CAGR of 6.6% from 2020 to 2027. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

Bayer Blogs

Show more

Bayer Frequently Asked Questions

  • When was Bayer founded?

    Bayer was founded in 1863.

  • Who are Bayer key executives?

    Bayer's key executives are Werner Baumann, Liam Condon and Wolfgang Nickl.

  • How many employees does Bayer have?

    Bayer has 103,824 employees.

  • What is Bayer revenue?

    Latest Bayer annual revenue is €43.5 b.

  • What is Bayer revenue per employee?

    Latest Bayer revenue per employee is €419.4 k.

  • Who are Bayer competitors?

    Competitors of Bayer include AstraZeneca, Roche and Novartis.

  • Where is Bayer headquarters?

    Bayer headquarters is located at Bayer Aktiengesellschaft, Kaiser-Wilhelm-Allee 1, Leverkusen.

  • Where are Bayer offices?

    Bayer has offices in Leverkusen, Bergkamen, Berlin, Bitterfeld-Wolfen and in 102 other locations.

  • How many offices does Bayer have?

    Bayer has 107 offices.